Journal
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION
Volume 12, Issue 6, Pages 403-409Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jamda.2011.04.014
Keywords
-
Categories
Funding
- Intramural NIH HHS [Z01 AG000015-49] Funding Source: Medline
Ask authors/readers for more resources
A consensus conference convened by the Society of Sarcopenia, Cachexia and Wasting Disorders has concluded that Sarcopenia, le, reduced muscle mass, with limited mobility should be considered an important clinical entity and that most older persons should be screened for this condition. Sarcopenia with limited mobility is defined as a person with muscle loss whose walking speed is equal to or less than 1 m/s or who walks less than 400 m during a 6-minute walk, and who has a lean appendicular mass corrected for height squared of 2 standard deviations or more below the mean of healthy persons between 20 and 30 years of age of the same ethnic group. The limitation in mobility should not clearly be a result of otherwise defined specific diseases of muscle, peripheral vascular disease with intermittent claudication, central and peripheral nervous system disorders, or cachexia. Clinically significant interventions are defined as an increase in the 6-minute walk of at least 50 meters or an increase of walking speed of at least 0.1 m/s. (J Am Med Dir Assoc 2011; 12: 403-409)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available